In the News

2014-07-15 - Kenneth S. Zaret, PhD, a nationally recognized leader in the fields of developmental and stem cell biology, has been named the new director of the Penn Institute for Regenerative Medicine (IRM). Zaret, who was the IRM associate director, is also the co-director of the Epigenetics Program in the Perelman School of Medicine at the University of Pennsylvania.
2014-06-19 - Research led by Ed Morrisey, PhD, professor of Medicine and Cell and Developmental Biology in the Perelman School of Medicine and scientific director of the Institute for Regenerative Medicine, has identified hundreds of these lncRNAs, sometimes called the “genomic dark matter,” that are expressed in developing and adult lungs. Their findings, described in and featured on the cover of the current issue of Genes and Development, reveal that many of these lncRNAs in the lung regulate gene expression by opening and closing the DNA scaffolding on neighboring genes.
2014-04-11 - The Institute for Regenerative Medicine hosted a Symposium on Cellular Reprogramming honoring Dr. John B. Gurdon, the 2012 Nobel Laureate in Physiology and Medicine.  This all-day event was attended by over 200 faculty, fellows and students at Penn and neighboring institutions.  
2014-03-21 - John Gearhart, PhD, director of the Institute for Regenerative Medicine, is featured in a cover story in the Philadelphia Business Journal about the region being on the brink of becoming a regenerative medicine research and business hub. Philadelphia already has a large inventory of scientific researchers and clinicians and a close proximity to many of the country’s major pharmaceutical companies. “One of the issues is how do we get all of these people together?,” Gearhart asked. “There is a desire to do it, but how do we do it? It’s difficult to build bridges. When does industry invest? How far ahead do you come in and make a large investment when the return is years and years away? What would be ideal is for [state] government to appreciate the economic potential for investing in a hub, perhaps partnering with academic [entities] and venture capital firms to make it a reality."